MDT Q4 2023 Earnings — Medtronic plc Revenue & Financial Results | Market Cap Arena

MDTMedtronic plc

$116B

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8.5B+5.6% YoY

Gross Profit

$5.6B65.1% margin

Operating Income

$1.6B18.3% margin

Net Income

$1.2B13.8% margin

EPS (Diluted)

$0.88

QoQ Revenue Growth

+10.6%

Cash Flow

Operating Cash Flow

$2.5B

Free Cash Flow

$2.1B

Stock-Based Comp.

$75M

Balance Sheet

Total Assets

$90.9B

Total Liabilities

$39.3B

Stockholders' Equity

$51.5B

Cash & Equivalents

$1.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8.5B	$8.1B	+5.6%
Gross Profit	$5.6B	$5.5B	+1.2%
Operating Income	$1.6B	$1.7B	-6.3%
Net Income	$1.2B	$1.5B	-20.6%

Revenue Segments

Cardiac and Vascular Group

$3.3B39%

Neuroscience Group

$2.4B28%

Medical Surgical

$2.2B26%

Diabetes Group

$595M7%

Geographic Segments

UNITED STATES

$4.5B52%

Total Other Countries, Excluding United States and Ireland

$4.0B47%

IRELAND

$27M0%